Obesity and kidney disease: Beyond the hyperfiltration

26Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage.

Author supplied keywords

Cite

CITATION STYLE

APA

Mascali, A., Franzese, O., Nisticò, S., Campia, U., Lauro, D., Cardillo, C., … Tesauro, M. (2016, September 1). Obesity and kidney disease: Beyond the hyperfiltration. International Journal of Immunopathology and Pharmacology. SAGE Publications Inc. https://doi.org/10.1177/0394632016643550

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free